Ethyl 4-(3-nitro-6-phenyl-7-piperidin-1-yl-1,8-naphthyridin-2-yl)piperazine-1-carboxylate | 364079-49-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: Ethyl 4-(3-nitro-6-phenyl-7-piperidin-1-yl-1,8-naphthyridin-2-yl)piperazine-1-carboxylate
• CAS: 364079-49-2
• 化学式: C₂₆H₃₀N₆O₄
• 分子量: 490.562
• InChiKey: INFINENJSITHCM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  36
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  108
• 氢给体数：
  0
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  Ethyl 4-(3-nitro-6-phenyl-7-piperidin-1-yl-1,8-naphthyridin-2-yl)piperazine-1-carboxylate 在 palladium on activated charcoal 氢气 作用下， 以 甲醇 为溶剂， 反应 3.0h， 以76%的产率得到Ethyl 4-(3-amino-6-phenyl-7-piperidin-1-yl-1,8-naphthyridin-2-yl)piperazine-1-carboxylate
  参考文献：
  名称：

  Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives

  摘要：

  Several 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives were synthesized and tested for their ability to inhibit human platelet aggregation in vitro induced by arachidonic acid, collagen and ADP. Only five compounds showed any appreciable activity, and the results of all the active derivatives were similar to those of papaverine in the test with arachidonic acid and collagen. Moreover, the most active compounds were investigated in the test with ADP and again showed a significant activity. The tested compounds that possessed the best activity were also shown to increase the c-AMP level significantly without involving the adenylyl cyclase system. (C) 2001 Elsevier Science S.A. All rights reserved.

  DOI：

  10.1016/s0014-827x(01)01075-8
• 作为产物：
  描述：

  N-哌嗪甲酸乙酯 、 2-Chloro-3-nitro-6-phenyl-7-piperidin-1-yl-1,8-naphthyridine 反应 16.0h， 以86%的产率得到Ethyl 4-(3-nitro-6-phenyl-7-piperidin-1-yl-1,8-naphthyridin-2-yl)piperazine-1-carboxylate
  参考文献：
  名称：

  Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives

  摘要：

  Several 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives were synthesized and tested for their ability to inhibit human platelet aggregation in vitro induced by arachidonic acid, collagen and ADP. Only five compounds showed any appreciable activity, and the results of all the active derivatives were similar to those of papaverine in the test with arachidonic acid and collagen. Moreover, the most active compounds were investigated in the test with ADP and again showed a significant activity. The tested compounds that possessed the best activity were also shown to increase the c-AMP level significantly without involving the adenylyl cyclase system. (C) 2001 Elsevier Science S.A. All rights reserved.

  DOI：

  10.1016/s0014-827x(01)01075-8

文献信息

• Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives
  作者：Pier Luigi Ferrarini、Muwaffag Badawneh、Flavia Franconi、Clementina Manera、Mauro Miceli、Claudio Mori、Giuseppe Saccomanni

  DOI：10.1016/s0014-827x(01)01075-8

  日期：2001.4

  Several 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives were synthesized and tested for their ability to inhibit human platelet aggregation in vitro induced by arachidonic acid, collagen and ADP. Only five compounds showed any appreciable activity, and the results of all the active derivatives were similar to those of papaverine in the test with arachidonic acid and collagen. Moreover, the most active compounds were investigated in the test with ADP and again showed a significant activity. The tested compounds that possessed the best activity were also shown to increase the c-AMP level significantly without involving the adenylyl cyclase system. (C) 2001 Elsevier Science S.A. All rights reserved.